A Prospective, Multicenter, Observation Study to Estimate the Dry Mouth in OAB Patients With Solifenacin.

Trial Profile

A Prospective, Multicenter, Observation Study to Estimate the Dry Mouth in OAB Patients With Solifenacin.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2014

At a glance

  • Drugs Solifenacin (Primary)
  • Indications Overactive bladder
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Feb 2013 Additional lead trial centers identified as reported by ClinicalTrials.gov.
    • 11 Feb 2013 Planned number of patients changed from 180 to 262 as reported by ClinicalTrials.gov record.
    • 07 Dec 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top